Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

AstraZeneca claims P2T antagonists for antiplatelet therapy

June 25, 2002

3-Dimensional presents new trypsin-like protease inhibitors in recent patent

June 20, 2002

Carrier-mediated active transport is responsible for hepatic uptake of Z-335

June 12, 2002

Novel factor Xa inhibitors claimed by Merck KGaA

June 11, 2002

Pharmion acquires Refludan rights outside North America

June 6, 2002

Daiichi patents factor Xa-inhibitory amidines

June 5, 2002

Aventis initiates Lovenox trial in patients with acute STEMI

June 4, 2002

Ajinomoto describes factor Xa-inhibitory benzodiazepines

June 4, 2002

Piperazine-containing factor Xa inhibitors patented by Cor Therapeutics (Millennium)

June 4, 2002

Quinolines and isoquinolines identified as factor Xa inhibitors

May 30, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...